Literature DB >> 27075452

[Methylphenidate in a patient with Alzheimer's disease : Increase in drive and cardiac performance].

Gerlinde Schuhfried1, Günter Schuhfried2.   

Abstract

The administration of methylphenidate (Ritalin®) to a patient with Alzheimer's disease who was in a critical condition (i.e. refusal of food, apathy and congestive heart failure) resulted in recovery to a stable health condition and stabilization of dementia. In this article various aspects of methylphenidate therapy in patients with Alzheimer's disease are presented.

Entities:  

Keywords:  Apathy; Attention; Dopamine; Heart failure; N-terminal pro-BNP

Mesh：

Substances：

Year:  2016        PMID： 27075452     DOI： 10.1007/s00391-016-1043-z

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN： 0948-6704            Impact factor:   1.281


  10 in total

1.  Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.

Authors:  Paul B Rosenberg; Krista L Lanctôt; Lea T Drye; Nathan Herrmann; Roberta W Scherer; David L Bachman; Jacobo E Mintzer
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

2.  Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults.

Authors:  Lori B Daniels; Gail A Laughlin; Donna Kritz-Silverstein; Paul Clopton; Wei-Chung Chen; Alan S Maisel; Elizabeth Barrett-Connor
Journal:  Am J Med       Date:  2011-07       Impact factor: 4.965

Review 3.  Use of psychostimulants in patients with dementia.

Authors:  Christian R Dolder; Lauren Nicole Davis; Jonathan McKinsey
Journal:  Ann Pharmacother       Date:  2010-08-24       Impact factor: 3.154

4.  Methylphenidate for apathy and functional status in dementia of the Alzheimer type.

Authors:  Prasad R Padala; William J Burke; Valerie K Shostrom; Subhash C Bhatia; Steven P Wengel; Jane F Potter; Frederick Petty
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

Review 5.  Treating apathy in Alzheimer's disease.

Authors:  Patricia A Boyle; Paul F Malloy
Journal:  Dement Geriatr Cogn Disord       Date:  2003-10-15       Impact factor: 2.959

6.  Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.

Authors:  Nathan Herrmann; Lana S Rothenburg; Sandra E Black; Michelle Ryan; Barbara A Liu; Usoa E Busto; Krista L Lanctôt
Journal:  J Clin Psychopharmacol       Date:  2008-06       Impact factor: 3.153

7.  Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.

Authors:  Krista L Lanctôt; Sarah A Chau; Nathan Herrmann; Lea T Drye; Paul B Rosenberg; Roberta W Scherer; Sandra E Black; Vijay Vaidya; David L Bachman; Jacobo E Mintzer
Journal:  Int Psychogeriatr       Date:  2013-10-29       Impact factor: 3.878

Review 8.  Depression and apathy in dementia: same syndrome or different constructs? A critical review.

Authors:  P Tagariello; P Girardi; M Amore
Journal:  Arch Gerontol Geriatr       Date:  2008-11-20       Impact factor: 3.250

9.  Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.

Authors:  Josef Marksteiner; Douglas Imarhiagbe; Michaela Defrancesco; Eberhard A Deisenhammer; Georg Kemmler; Christian Humpel
Journal:  Exp Gerontol       Date:  2013-12-10       Impact factor: 4.032

Review 10.  Apathy in Alzheimer's disease: any effective treatment?

Authors:  Raffaele Rea; Anna Carotenuto; Angiola M Fasanaro; Enea Traini; Francesco Amenta
Journal:  ScientificWorldJournal       Date:  2014-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.